---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-355550"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-08-18T20:27:36+00:00"
generated_at: "2026-08-18T20:29:06.301388+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics adjourns special meeting again; needs 75% vote for governance change

## Summary
- Special meeting reconvened Aug 17, 2026, adjourned again due to insufficient votes for proposal.
- Quorum present: 10,601,849 shares (71.6% of 14,806,997 outstanding as of May 28, 2026 record date).
- Proposal: replace supermajority voting requirements and permit stockholder action by written consent; requires 75% affirmative vote.
- Meeting reconvenes Sept 15, 2026 at 12:00 p.m. ET via webcast; record date unchanged.
- Proxies previously submitted will be voted unless revoked; no changes to proposal.

## SEC filing metadata
- accession: 0001193125-26-355550
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-08-18T20:27:36+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312526355550/0001193125-26-355550-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526355550/d919907d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-355550
- JSON: https://secwatch.observer/filing/0001193125-26-355550.json
- Plain text: https://secwatch.observer/filing/0001193125-26-355550.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.